Skip to main content
. 2020 Oct 21;10:17899. doi: 10.1038/s41598-020-74882-4

Figure 2.

Figure 2

Characterization of PDX models. (A) Oncoplot of the most frequently mutated genes found in our PDX cohort and also found in TNBC22. Genomic samples from patients are denoted with a PT_ prefix prepended to their respective PDX surrogate. (B) Molecular subtypes determined from PDX gene expression profile: BL1, basal-like 1; BL2, basal-like 2; IM, immunomodulatory; LAR, luminal androgen receptor; M, mesenchymal; UNS, unstable. (C) Correlative analysis of the 1000 most variant gene transcripts from RNA sequencing between patient tumors and PDX model.